Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters
Liu Y, Nancy G. Azizian, Delaney K. Sullivan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

DeepTraSynergy: drug combinations using multimodal deep learning with transformers
Fatemeh Rafiei, Hojjat Zeraati, Karim Abbasi, et al.
Bioinformatics (2023) Vol. 39, Iss. 8
Open Access | Times Cited: 40
Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective
Tania B. López-Méndez, Miguel Sánchez‐Álvarez, Flavia Trionfetti, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25
m6A RNA methylation orchestrates transcriptional dormancy during paused pluripotency
Évelyne Collignon, Brandon Cho, Giacomo Furlan, et al.
Nature Cell Biology (2023) Vol. 25, Iss. 9, pp. 1279-1289
Closed Access | Times Cited: 23
mTOR pathway occupies a central role in the emergence of latent cancer cells
Kseniia V. Aleksandrova, Mikhail L. Vorobev, Irina I. Suvorova
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 12
Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies
Jun He, Zejing Qiu, Jingjing Fan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Sonocatalytic In Situ Induced Oxygen Storm Precision Enhanced Reactive Oxygen Therapy for Pancreatic Cancer
Meifang Zhang, Lile Dong, Li Dong, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 41
Closed Access | Times Cited: 17
mTORC2-driven chromatin cGAS mediates chemoresistance through epigenetic reprogramming in colorectal cancer
Guoqing Lv, Qian Wang, Lin Lin, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 9, pp. 1585-1596
Open Access | Times Cited: 4
Targeting protein synthesis pathways in MYC-amplified medulloblastoma
Devendra Kumar, Ranjana Kanchan, Nagendra K. Chaturvedi
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Comparative Analysis of Transcriptomic and Proteomic Expression between Two Non-Small Cell Lung Cancer Subtypes
Ben Nicholas, A.G. Bailey, Katy J. McCann, et al.
Journal of Proteome Research (2025) Vol. 24, Iss. 2, pp. 729-741
Open Access
Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer
Tackhoon Kim, Byung-Sun Park, Soobeen Heo, et al.
(2025)
Open Access
Potentiation of Sorafenib’s Action by Berberine via Suppression of the mTOR Signaling Pathway in Human Hepatoma Cells
Rongrong Zhang, Na Wang, Bo Fan, et al.
Nutrition and Cancer (2025), pp. 1-13
Closed Access
Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer
Tackhoon Kim, Byung-Sun Park, Soobeen Heo, et al.
eLife (2025) Vol. 13
Open Access
Silk Fibroin-Based Injectable Hydrogel Encapsulated with Layered Double Hydroxide for Tumor Therapy via Continuous Radical Generation
Yongjia Zhang, Mengcheng Tang, Beibei Wang, et al.
ACS Applied Nano Materials (2025)
Closed Access
A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics
Hyeong-Min Lee, William C. Wright, Min Pan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Unveiling the role of cellular dormancy in cancer progression and recurrence
Évelyne Collignon
Current Opinion in Oncology (2024) Vol. 36, Iss. 2, pp. 74-81
Open Access | Times Cited: 3
Precision Treatment of Colon Cancer Using Doxorubicin-Loaded Metal–Organic-Framework-Coated Magnetic Nanoparticles
Honglin Jiang, Qing Bao, Tao Yang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 37, pp. 49003-49012
Open Access | Times Cited: 3
Diapause-like Drug-Tolerant Persister State: The Key to Nirvana Rebirth
Hanlin Chen, Weilin Jin
Medicina (2024) Vol. 60, Iss. 2, pp. 228-228
Open Access | Times Cited: 2
Defensins: Exploring Their Opposing Roles in Colorectal Cancer Progression
Hussein Sabit, Timothy M. Pawlik, Shaimaa Abdel-Ghany, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2622-2622
Open Access | Times Cited: 2
Self‐Boosting Programmable Release of Multiple Therapeutic Agents by Activatable Heterodimeric Prodrug‐Enzyme Assembly for Antitumor Therapy
Shanshan Jiang, Bhaskar Gurram, Junfei Zhu, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Epstein–Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mTOR and HIF-1α
Ryan Incrocci, Rosalinda Monroy Del Toro, Grace Devitt, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3944-3944
Open Access | Times Cited: 2
Hypertranscription: the invisible hand in stem cell biology
Yun‐Kyo Kim, Évelyne Collignon, S Bryn Martin, et al.
Trends in Genetics (2024)
Closed Access | Times Cited: 2
Doxorubicin-induced senescence promotes resistance to cell death by modulating genes associated with apoptotic and necrotic pathways in prostate cancer DU145 CD133+/CD44+ cells
Cansu Tatar, Çığır Biray Avcı, Eda Açıkgöz, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 680, pp. 194-210
Closed Access | Times Cited: 6
Pan-cancer transcriptional atlas of minimal residual disease links DUSP1 to chemotherapy persistence
Liu Y, Bi Peng, Ziqi Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Chemotherapy’s effects on autophagy in the treatment of Hodgkin’s lymphoma: a scoping review
Roro Wahyudianingsih, Ardo Sanjaya, Timothy Jonathan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Pure Squamous Cell Carcinoma of the Prostate With a Complete Remission to Gemcitabine-Cisplatin: Case Presentation and Literature Review
Yang Yang, Yilin Shen, Kevin Zarrabi, et al.
JU Open Plus (2024) Vol. 2, Iss. 10
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top